Another Paragon offshoot chooses reverse merger, this time for migraine drugs

They say stick to what you know. And Paragon Therapeutics knows how to do reverse mergers. In a deal announced Tuesday, the hub-and-spoke biologics company is moving its migraine drug offshoot ...